Innovation Days 2010, at the crossroads between Pharma & Biotech sector

Universal Medica Group is pleased to announce the Innovation Days 2010, a Pharma & Biotech event to be held in Paris, on 4th & 5th October, 2010.
The aim of the Innovation Days is to bring together people from Biotech and Pharmaceutical companies, encourage innovative talent and the development of bio-industries.

A unique event connecting people from Pharma & Biotech companies:
Protagonists from the pharmaceutical industry and the biotech sector will have the opportunity to communicate, share experience and discuss the main issues and challenges of the Healthcare sector.
During the first day of the Innovation Days, the major tendencies and strategic orientations in the healthcare marketplace will be highlighted.
The second day, dedicated to the Biotech sector, will give an overview of main players and partnering opportunities through illustration of concrete concerns.
This event aims to put forward promising innovations and to bring together companies and institutional representatives, and support organisms to share their experience. 600 visitors are expected.

The Awarding Ceremony of the Innovation Grant 2010 :
These 2 days of exchanges and debates will be concluded by the Awarding Ceremony of the Innovation Grant 2010.
Dedicated to academic researchers and Young Innovative Companies, the Innovation Grant rewards, at the European level, innovative biotechnology based therapeutic and medical research projects.

Who is attending?
- Representatives from the Pharmaceutical and Biotech companies will present their activity;
- Institutional partners and supporting Healthcare structures;
- Candidates to the Innovation Grant 2010: Young Innovative Companies and academic researchers will exhibit their projects, exchange with companies representatives and eventually develop partnerships;
- Jury members of the Innovation Grant 2010, experts coming from the biopharmaceutical sector and European Institutions;
- Researchers, pharmaceuticals representatives, Healthcare Institutes, clusters… are warmly welcome!

Speakers :

Géraud d'Argenlieu, SANTEOS
Stéphane Sclison, IMS HEALTH
Alexandre Williams, ETYPHARM
Jean-Pierre Favier, JANSSEN CILAG
Rémi Vernier, BAYER SCHERING
Philippe Duperray, VISITE ACTUELLE
Martine Aoustin, ARS LANGUEDOC-ROUSSILLON
Fabienne Pioch, BRISTOL-MYERS-SQUIBB
Christian Saout, CISS
Cédric Grouchka, HAS
Davis-Romain Bertholon, EMPATIENT
Sébastien Pradeau, SAVIN MARTINET ASSOCIES
Florence Denonain, JANSSEN CILAG
Anne Debbasch, JANSSEN CILAG
Anne Pezet, USINE NOUVELLE
Ruxandra Draghia-Akli, DG RECHERCHE COMMISSION EUROPEENNE
Stéphane Palies, AFSSAPS
Jean-Louis Dasseux, CERENIS THERAPEUTICS
Mohammed Charki, SANOFI-AVENTIS
André Choulika, FRANCE BIOTECH
Catherine Borg Capra, OSEO
Patrick Chaussepied, ANR
Bernard Pau, INSTITUT D'ETUDES THERAPEUTIQUES
Jean-Claude Hildeilfinger, ADEBIOTECH
Stéphanie Lefebvre, PARIS BIOTECH SANTE
Tristan Rousselle, PX’THERAPEUTICS
Florence Ghrenassia, AP-HP DIRC ILE DE FRANCE
Jean Deregnaucourt, INSTITUT PASTEUR
Manfred Horst, MSD
Bernard Gilly, FOVEA PHARMACEUTICALS
David Sourdive, CELLECTICS
Pierre-Noël Lirsac, LFB
Pierre-Emmanuel Aubert, ANGELS SANTE
Laurent Arthaud, CDC ENTREPRISES
Patrice Denefle, IPSEN
Aaron Bensimon, GENOMIC VISION
Bernard Mandrand, LYON BIOPOLE
Jean-Yves Prax, POLIA CONSULTING
Jean Hache, ESIEE MANAGEMENT
Els Vanheusden, CAPRICORN VENTURE PARTNERS

For further information: http://www.universal-biotech.com/lang-en/innova...